Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | MAP2K1 |
| Variant | K59del |
| Impact List | deletion |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | MAP2K1 K59del results in the deletion of an amino acid in the protein kinase domain of the Map2k1 protein at amino acid 59 (UniProt.org). K59del results in autophosphorylation levels (PMID: 29753091), and proliferation in low serum conditions in a competition assay similar to wild-type Map2k1 (PMID: 36442478), but demonstrates increased Mek/Erk activation in other studies (PMID: 22389471, PMID: 40274952), increased proliferation in a competition assay in normal serum conditions, increased transformation activity (PMID: 36442478), increased basal cell metabolism, and is associated with decreased sensitivity to some Mek and Raf inhibitors in culture (PMID: 40274952), and therefore, is predicted to lead to a gain of Map2k1 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
MAP2K1 mutant MAP2K1 inact mut MAP2K1 K59del |
| Transcript | NM_002755.4 |
| gDNA | chr15:g.66435121_66435123delAAG |
| cDNA | c.175_177delAAG |
| Protein | p.K59delK |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_011521783.4 | chr15:g.66435190_66435192delGTG | c.178_180delGTG | p.V60delV | RefSeq | GRCh38/hg38 |
| XM_017022413.1 | chr15:g.66485000_66485002delTCC | c.176_178delTCC | p.L59delL | RefSeq | GRCh38/hg38 |
| NM_001411065.1 | chr15:g.66435190_66435192delGTG | c.178_180delGTG | p.V60delV | RefSeq | GRCh38/hg38 |
| XM_011521783.3 | chr15:g.66435190_66435192delGTG | c.178_180delGTG | p.V60delV | RefSeq | GRCh38/hg38 |
| NM_002755 | chr15:g.66435121_66435123delAAG | c.175_177delAAG | p.K59delK | RefSeq | GRCh38/hg38 |
| XM_011521783 | chr15:g.66435190_66435192delGTG | c.178_180delGTG | p.V60delV | RefSeq | GRCh38/hg38 |
| XM_017022412 | chr15:g.66435190_66435192delGTG | c.178_180delGTG | p.V60delV | RefSeq | GRCh38/hg38 |
| NM_002755.4 | chr15:g.66435121_66435123delAAG | c.175_177delAAG | p.K59delK | RefSeq | GRCh38/hg38 |
| XM_017022411.3 | chr15:g.66435121_66435123delAAG | c.175_177delAAG | p.K59delK | RefSeq | GRCh38/hg38 |
| XM_017022413 | chr15:g.66485000_66485002delTCC | c.176_178delTCC | p.L59delL | RefSeq | GRCh38/hg38 |
| NM_002755.3 | chr15:g.66435121_66435123delAAG | c.175_177delAAG | p.K59delK | RefSeq | GRCh38/hg38 |
| XM_017022412.1 | chr15:g.66435190_66435192delGTG | c.178_180delGTG | p.V60delV | RefSeq | GRCh38/hg38 |
| XM_017022411 | chr15:g.66435121_66435123delAAG | c.175_177delAAG | p.K59delK | RefSeq | GRCh38/hg38 |
| XM_017022411.2 | chr15:g.66435121_66435123delAAG | c.175_177delAAG | p.K59delK | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|